Gemcitabine Hydrochloride/Docetaxel

盐酸吉西他滨/多西他赛

Report date: 2026/05/02 20:00:18

Base Information

Drug NameGemcitabine Hydrochloride/Docetaxel
Drug Alias Namegem/doceDocetaxel/gemcitabine controlled releaseNDV01NDV-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRibonucleotide reductase inhibitorsDNA inhibitorsTubulin depolymerization inhibitors
TargetsDNARibonucleotide reductaseTubulin
Therapy Area/IndicationsUrinary Bladder NeoplasmsUrologic NeoplasmsCarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsYes Gemcitabine HydrochlorideDocetaxel
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrigone Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRelmada Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsUrologic NeoplasmsCarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A